791 related articles for article (PubMed ID: 24424197)
1. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
Drori T; Chapman J
Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
[TBL] [Abstract][Full Text] [Related]
2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
3. Devic's index case: A critical reappraisal - AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?
Jarius S; Wildemann B
J Neurol Sci; 2019 Dec; 407():116396. PubMed ID: 31726278
[TBL] [Abstract][Full Text] [Related]
4. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
5. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica: clinical features, immunopathogenesis and treatment.
Jarius S; Wildemann B; Paul F
Clin Exp Immunol; 2014 May; 176(2):149-64. PubMed ID: 24666204
[TBL] [Abstract][Full Text] [Related]
7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
8. Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
Jacob A; McKeon A; Nakashima I; Sato DK; Elsone L; Fujihara K; de Seze J
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):922-30. PubMed ID: 23142960
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica (Devic's syndrome).
Wingerchuk DM; Weinshenker BG
Handb Clin Neurol; 2014; 122():581-99. PubMed ID: 24507536
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of neuromyelitis optica.
Levy M; Wildemann B; Jarius S; Orellano B; Sasidharan S; Weber MS; Stuve O
Adv Immunol; 2014; 121():213-42. PubMed ID: 24388217
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
12. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
Juryńczyk M; Weinshenker B; Akman-Demir G; Asgari N; Barnes D; Boggild M; Chaudhuri A; D'hooghe M; Evangelou N; Geraldes R; Illes Z; Jacob A; Kim HJ; Kleiter I; Levy M; Marignier R; McGuigan C; Murray K; Nakashima I; Pandit L; Paul F; Pittock S; Selmaj K; de Sèze J; Siva A; Tanasescu R; Vukusic S; Wingerchuk D; Wren D; Leite I; Palace J
J Neurol; 2016 Jan; 263(1):140-9. PubMed ID: 26530512
[TBL] [Abstract][Full Text] [Related]
13. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
Asgari N; Skejø HP; Lillevang ST; Stenager E
Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis optica.
Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
[TBL] [Abstract][Full Text] [Related]
15. [Devic's neuromyelitis optica: diagnosis after 10 years of bilateral severe relapsing optic neuritis].
Déral-Stéphant V; Roux-Lelièvre C; Vignal R; Stéphant E; Faivre A; Alla P
J Fr Ophtalmol; 2008 Sep; 31(7):705-9. PubMed ID: 18971856
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
Asgari N
Dan Med J; 2013 Oct; 60(10):B4730. PubMed ID: 24083534
[TBL] [Abstract][Full Text] [Related]
17. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
Jordan B; Eger K; Kornhuber ME; Zierz S
Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
20. A Rare Variant of Neuromyelitis Optica.
Choudhury A; Chakraborty A; Bhattacharyya AK
J Assoc Physicians India; 2018 Oct; 66(10):86-87. PubMed ID: 31317719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
